<DOC>
	<DOCNO>NCT00689013</DOCNO>
	<brief_summary>The purpose study determine whether pharmacist-driven patient intervention effect number herpes zoster ( Zostavax ) vaccination give community pharmacy setting .</brief_summary>
	<brief_title>The Effect Pharmacist Intervention Use Zostavax Community Pharmacy Setting</brief_title>
	<detailed_description>Several study exist document perception satisfaction patient receive immunization pharmacist , well effect pharmacist involvement advocate administer vaccination . The well documented study conduct hospital setting . Undoubtedly , enormous opportunity community pharmacist identify potential vaccine recipient , advocate immunization administer say immunization establish patient population . However , lack concentrated study implementation immunization service community set effect . The investigator intend evaluate intervention pharmacist immunization program resulting change immunization rate .</detailed_description>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>men woman age 60 old without contraindication herpes zoster vaccination patient already experience one episode herpes zoster infection consider vaccine receipt study inclusion secondary CDC ACIP recommendation Patients age &lt; 60 year Anyone previously receive herpes zoster vaccine Anyone allergy neomycin , gelatin component vaccine Anyone receive live vaccine within 4 week Anyone compromise weaken immune system receive radiation , corticosteroid , HIV/AIDS , cancer lymph , bone blood system Pregnant woman close contact pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Herpes Zoster</keyword>
	<keyword>Prevention &amp; control</keyword>
	<keyword>Pharmacists</keyword>
	<keyword>Pharmacy</keyword>
	<keyword>Pharmacies</keyword>
	<keyword>Aged</keyword>
	<keyword>Immunization</keyword>
	<keyword>Vaccination</keyword>
</DOC>